Evernest Financial Advisors LLC Purchases Shares of 19,500 LENSAR, Inc. (NASDAQ:LNSR)

Evernest Financial Advisors LLC purchased a new stake in shares of LENSAR, Inc. (NASDAQ:LNSRFree Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 19,500 shares of the company’s stock, valued at approximately $174,000.

Separately, Sanctuary Advisors LLC bought a new stake in shares of LENSAR in the 2nd quarter valued at about $93,000. 40.15% of the stock is owned by hedge funds and other institutional investors.

LENSAR Price Performance

LNSR opened at $11.10 on Friday. The stock’s 50 day simple moving average is $8.39 and its 200 day simple moving average is $6.27. The firm has a market cap of $128.87 million, a price-to-earnings ratio of -7.60 and a beta of 0.63. LENSAR, Inc. has a 1 year low of $2.67 and a 1 year high of $11.90.

LENSAR (NASDAQ:LNSRGet Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.13) earnings per share (EPS) for the quarter. LENSAR had a negative return on equity of 49.02% and a negative net margin of 34.03%. The firm had revenue of $13.54 million during the quarter.

About LENSAR

(Free Report)

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.

Featured Stories

Want to see what other hedge funds are holding LNSR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LENSAR, Inc. (NASDAQ:LNSRFree Report).

Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.